Literature DB >> 17319929

Prevalence of CARD15/NOD2 mutations in Caucasian healthy people.

Jean-Pierre Hugot1, Isabelle Zaccaria, Juleen Cavanaugh, Huiying Yang, Séverine Vermeire, Maarit Lappalainen, Stefan Schreiber, Vito Annese, Derek P Jewell, Elizabeth V Fowler, Steven R Brant, Mark S Silverberg, Judy Cho, John D Rioux, Jack Satsangi, Miles Parkes.   

Abstract

BACKGROUND: Crohn's disease (CD) has been associated with CARD15/NOD2 mutations in Caucasians. The R702W, G908R, and 1007fs mutations represent 82% of the mutated chromosomes. The relative risk of developing CD in homozygous or compound heterozygous people has been estimated as between 10 and 40 times that of the general population. This high risk may support the opinion that CARD15/NOD2 variants are strong CD risk factors at the individual and population levels. SUBJECTS AND METHODS: The allele and genotype frequencies were calculated for the R702W, G908R, and 1007fs mutations in 3,575 Caucasian healthy controls recruited by 15 groups distributed on three continents. Geographic homogeneity was tested and the observed proportion of double mutants was compared with the expected value using chi2 tests.
RESULTS: The allele frequencies of the R702W, G908R, and 1007fs mutations were 4.3% (3.6-4.9), 1.2% (0.8-1.6), and 2.3% (1.8-2.8), respectively, with large geographic fluctuations of the G908R, 1007fs, and wild-type alleles (P<0.0001). At the population level, no simple relationship was observed between mutation frequencies and the disease incidences in the studied populations. At the individual level, no significant deficit of double-dose mutation carriers among healthy controls was found, providing strong evidence that the penetrances of the most at-risk genotypes are low.
CONCLUSION: Altogether, these data confirm that CARD15/NOD2 acts in interaction with other unknown risk cofactors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17319929     DOI: 10.1111/j.1572-0241.2007.01149.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  50 in total

1.  Dissecting the genetics of complex inheritance: linkage disequilibrium mapping provides insight into Crohn disease.

Authors:  Heather Elding; Winston Lau; Dallas M Swallow; Nikolas Maniatis
Journal:  Am J Hum Genet       Date:  2011-12-09       Impact factor: 11.025

2.  Bin1: a new player in IBD barrier dysfunction.

Authors:  Hyunji Ryu; Daniela Posca; Terrence Barrett
Journal:  Dig Dis Sci       Date:  2012-05-30       Impact factor: 3.199

3.  NOD2 polymorphisms in clinical phenotypes of common variable immunodeficiency disorders.

Authors:  K Packwood; E Drewe; E Staples; D Webster; T Witte; J Litzman; W Egner; R Sargur; W Sewell; E Lopez-Granados; S L Seneviratne; R J Powell; B L Ferry; H M Chapel
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

4.  Phenotypic Variation in Paediatric Inflammatory Bowel Disease by Age: A Multicentre Prospective Inception Cohort Study of the Canadian Children IBD Network.

Authors:  J Dhaliwal; T D Walters; D R Mack; H Q Huynh; K Jacobson; A R Otley; J Debruyn; W El-Matary; C Deslandres; M E Sherlock; J N Critch; K Bax; E Seidman; P Jantchou; A Ricciuto; M Rashid; A M Muise; E Wine; M Carroll; S Lawrence; J Van Limbergen; E I Benchimol; P Church; A M Griffiths
Journal:  J Crohns Colitis       Date:  2020-05-21       Impact factor: 9.071

5.  Insufficient evidence for association of NOD2/CARD15 or other inflammatory bowel disease-associated markers on GVHD incidence or other adverse outcomes in T-replete, unrelated donor transplantation.

Authors:  Yume Nguyen; Abed Al-Lehibi; Elizabeth Gorbe; Ellen Li; Michael Haagenson; Tao Wang; Stephen Spellman; Stephanie J Lee; Nicholas O Davidson
Journal:  Blood       Date:  2010-02-22       Impact factor: 22.113

6.  The TLR2-MyD88-NOD2-RIPK2 signalling axis regulates a balanced pro-inflammatory and IL-10-mediated anti-inflammatory cytokine response to Gram-positive cell walls.

Authors:  Lilian O Moreira; Karim C El Kasmi; Amber M Smith; David Finkelstein; Sophie Fillon; Yun-Gi Kim; Gabriel Núñez; Elaine Tuomanen; Peter J Murray
Journal:  Cell Microbiol       Date:  2008-06-28       Impact factor: 3.715

Review 7.  The immunopathogenesis of Crohn's disease: a three-stage model.

Authors:  Gavin W Sewell; Daniel Jb Marks; Anthony W Segal
Journal:  Curr Opin Immunol       Date:  2009-08-08       Impact factor: 7.486

8.  Donor TLR9 gene tagSNPs influence susceptibility to aGVHD and CMV reactivation in the allo-HSCT setting without polymorphisms in the TLR4 and NOD2 genes.

Authors:  H W Xiao; Y Luo; X Y Lai; J M Shi; Y M Tan; J S He; W Z Xie; W Y Zheng; X J Ye; X H Yu; Z Cai; M F Lin; H Huang
Journal:  Bone Marrow Transplant       Date:  2013-10-14       Impact factor: 5.483

9.  Phenotypic and genotypic characteristics of inflammatory bowel disease in French Canadians: comparison with a large North American repository.

Authors:  Mamatha Bhat; Geoffrey C Nguyen; Pierre Pare; Raymond Lahaie; Colette Deslandres; Edmond-Jean Bernard; Guy Aumais; Gilles Jobin; Gary Wild; Albert Cohen; Diane Langelier; Steven Brant; Themistocles Dassopoulos; Dermot McGovern; Esther Torres; Richard Duerr; Miguel Regueiro; Mark S Silverberg; Hillary Steinhart; Anne M Griffiths; Abdul Elkadri; Judy Cho; Deborah Proctor; Philippe Goyette; John Rioux; Alain Bitton
Journal:  Am J Gastroenterol       Date:  2009-06-09       Impact factor: 10.864

10.  Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease.

Authors:  Andrew M Smith; Farooq Z Rahman; Bu'Hussain Hayee; Simon J Graham; Daniel J B Marks; Gavin W Sewell; Christine D Palmer; Jonathan Wilde; Brian M J Foxwell; Israel S Gloger; Trevor Sweeting; Mark Marsh; Ann P Walker; Stuart L Bloom; Anthony W Segal
Journal:  J Exp Med       Date:  2009-08-03       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.